COVID-19 Impact to the Global Surgical Masks and Respirators Market – New Forecast Released by LSI

Global sales of surgical masks and respirators are projected to reach over $10 billion in 2020. This number represents a massive increase over historical data LSI has been reporting for the last decade.

HUNTINGTON BEACH, Calif.–(BUSINESS WIRE)–#lsintelligenceLife Science Intelligence (LSI) has been tracking and publishing market data on the global surgical apparel market and protective personal equipment (PPE) market for the last decade. LSI’s new market report, Global Opportunities in Surgical Masks and Respirators Market – Impact Analysis of Coronavirus Outbreak provides a reliable and independent forecast of the COVID-19 impact to these markets.

According to the new report, global sales of surgical masks and respirators will exceed pre-pandemic estimates for these products by 211% and 305%, respectively. In 2020, global sales of surgical masks and respirators are projected to reach between $8.0 and $10.7 billion, depending on how the virus spreads. A massive increase in demand for these products, coupled with unit shortages, have caused average sale prices to increase by as much as 4X.

The report features three projected forecasts that take into consideration different scenarios of transmission and containment. These forecasts project revenue and units distributed assuming contained, sustained, and widespread transmission of the virus.

Companies covered in this analysis include: 3M (MMM), Cardinal Health (CAH), Honeywell International (HON), Premier, Prestige Ameritech, Alpha Pro Tech (APT), Makrite Industries, Moldex Metric, Aero Pro, Louis M. Gerson Company, Shanghai Dasheng Health Products, Foss Performance Materials, Hakugen Earth, and Shanghai Gangkai Purifying Products Company, among others.

More about this report and other medical device & diagnostic markets impacted by COVID-19 and the corresponding financial crisis can be found here: https://www.lifesciencemarketresearch.com/market-reports

About Life Science Intelligence (LSI)

LSI is a medical technology focused market intelligence & consulting company. We help medtech executives make informed strategic decisions by better understanding market dynamics, trends, opportunities and the competitive landscape.

Contacts

Scott Pantel

Life Science Intelligence

714 847 3540 Tel

scott@LS-intel.com

Staff

Recent Posts

ONWARD® Medical Obtains Debt Financing with up to €52.5 Million Secured Loan from Runway Growth Capital LLC

THIS PRESS RELEASE CONTAINS INSIDE INFORMATION WITHIN THE MEANING OF ARTICLE (7)(1) OF THE EUROPEAN…

1 day ago

LSL Pharma Group Announces Voting Results of Its Annual and Special Meeting of Shareholders

BOUCHERVILLE, Québec, June 28, 2024 (GLOBE NEWSWIRE) -- LSL PHARMA GROUP INC. (TSXV: LSL, LSL.DB)…

1 day ago

Lowell Farms Inc. Announces Change of Chief Financial Officer

SALINAS, Calif., June 28, 2024 (GLOBE NEWSWIRE) -- Lowell Farms Inc. (the “Company”) (CSE: LOWL;…

1 day ago

PetVivo Reports Reports Fiscal 2024 Results

MINNEAPOLIS, MN, US, June 28, 2024 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (OTC: PETV, PETVW),…

1 day ago

Gain Therapeutics to Hold a Business Update Conference Call on July 1, 2024

BETHESDA, Md., June 28, 2024 (GLOBE NEWSWIRE) -- Gain Therapeutics, Inc. (Nasdaq: GANX) (“Gain”, or…

1 day ago

Cellectis Reports Results from Shareholders Meeting Held on June 28, 2024

NEW YORK, June 28, 2024 (GLOBE NEWSWIRE) -- Cellectis (Euronext Growth: ALCLS; Nasdaq: CLLS), a…

1 day ago